We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Many HIV Screening Tests Yield False-Positive Results

By LabMedica International staff writers
Posted on 23 Mar 2010
A positive screening test for human immunodeficiency virus (HIV) means only that there are antibodies present either to HIV or to something that cross-reacts with it. More...
The test does not mean that a person has or will get acquired immunodeficiency syndrome (AIDS).

In many jurisdictions, tests for HIV are required screening for pregnant women. It has been suggested that the entire population be screened for HIV. The rationale is to prevent transmission of the virus by administration of antiretroviral drugs to individuals who receive positive results from the screening tests.

However, people receiving false-positive results from the HIV screening test might not be infected with the virus. However, they will be told that they have acquired immunodeficiency disease (AIDS) and be required to take expensive, toxic drugs for a condition they cannot transmit because they do not have it.

"The problem of false-positive tests applies to all screening tests, not just HIV," stated Jane M. Orient, M.D., executive director of the Association of American Physicians and Surgeons (AAPS; Arlington, VA, USA). "If a population with a very low likelihood of a disease is tested, there will be very few positive tests. But even with an excellent test, a positive is more likely than not to be a false positive."

Dr. Orient added that although the test is a very good for screening blood donors it can do more harm than good if used to screen the entire population.

An article by Henry H. Bauer, Ph.D., professor emeritus of chemistry and science studies, and dean emeritus of arts and sciences at Virginia Polytechnic Institute and State University (Virginia Tech; Blacksburg, VA, USA) appeared in the spring edition of the Journal of American Physicians and Surgeons. It explains the history behind the HIV screening tests, and the reason such a large proportion of them are likely to give false-positive results.

Related Links:
Association of American Physicians and Surgeons
Virginia Polytechnic Institute and State University
Journal of American Physicians and Surgeons




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.